Citation Impact
Citing Papers
Acetaminophen-induced Liver Injury: from Animal Models to Humans
2014
Neutrophil Extracellular Traps Are Markers of Wound Healing Impairment in Patients with Diabetic Foot Ulcers Treated in a Multidisciplinary Setting
2019
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Fasting-induced hormonal regulation of lysosomal function
2017
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
2014
Cell type-selective secretome profiling in vivo
2020 StandoutNobel
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
A review on the biology and properties of adipose tissue macrophages involved in adipose tissue physiological and pathophysiological processes
2020
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
The role of Gut Microbiota in the development of obesity and Diabetes
2016
NETosis is induced by high glucose and associated with type 2 diabetes
2014
Macrophages in immunoregulation and therapeutics
2023 Standout
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
Hepatocellular carcinoma
2021 Standout
An emerging role for neutrophil extracellular traps in noninfectious disease
2017
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Pathophysiology of NASH: Perspectives for a Targeted Treatment
2013
Interaction between microbiota and immunity in health and disease
2020 Standout
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Neutrophil extracellular traps in immunity and disease
2017 Standout
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
2018
The intestinal microbiota fuelling metabolic inflammation
2019
Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance
2018
Role of the gut microbiota in nutrition and health
2018 Standout
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
2015
Dysbiosis of the gut microbiota in disease
2015 Standout
Vitamin C intake potentially lowers total cholesterol to improve endothelial function in diabetic patients at increased risk of cardiovascular disease: A systematic review of randomized controlled trials
2022
Comprehensive Metabolomic Characterization of Coronary Artery Diseases
2016
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Ulcerative colitis
2020 Standout
The immunology of hepatocellular carcinoma
2018
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways
2015
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome
2019
GnRH impairs diabetic wound healing through enhanced NETosis
2019
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Gut microbiota and non-alcoholic fatty liver disease: new insights
2013
Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation
2018
Gut microbiota in human metabolic health and disease
2020 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Diet and exercise in NAFLD/NASH: Beyond the obvious
2021
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes
2019
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
2020
Recent advances in the development of farnesoid X receptor agonists.
2015
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
2017
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Wound Healing: A Cellular Perspective
2018 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Liver inflammation and fibrosis
2017
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Dewei Ye being referenced
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice
2012
Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation
2019
Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise
2020
Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
2014
Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
2019
Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2
2016
Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice
2016
Toll‐like receptor‐4 signalling in the progression of non‐alcoholic fatty liver disease induced by high‐fat and high‐fructose diet in mice
2014
Relationship of serum uric acid level with non‐alcoholic fatty liver disease and its inflammation progression in non‐obese adults
2016
Increased Neutrophil Elastase and Proteinase 3 and Augmented NETosis Are Closely Associated With β-Cell Autoimmunity in Patients With Type 1 Diabetes
2014
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
2015
Increased ratio of neutrophil elastase to α1‐antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis
2015